Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3422)
All Articles published online
|
Dec 15, 2000 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh P, Indaram A, Greenberg R, Visvalingam V, Bank S. Long term omeprazole therapy for reflux esophagitis: Follow-up in serum gastrin levels, EC cell hyperplasia and neoplasia. World J Gastroenterol 2000; 6(6): 789-792 [PMID: 11819697 DOI: 10.3748/wjg.v6.i6.789] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i6/789.htm |
| Number | Citing Articles |
| 1 |
Yvan Vandenplas, Hegar Badriul, Sylvia Salvatore, Bruno Hauser. Pharmacotherapy of gastro-oesophageal reflux disease in children: focus on safety. Expert Opinion on Drug Safety 2002; 1(4): 355 doi: 10.1517/14740338.1.4.355
|
| 2 |
Yvan Vandenplas, Silvia Salvatore, Bruno Hauser. The Gastroesophageal Reflux in Infants and Children. 2004; : 147 doi: 10.1007/978-3-642-18906-7_19
|
| 3 |
M.E. Numans. Vademecum permanente nascholing huisartsen. 2006; : 1635 doi: 10.1007/978-90-313-8808-0_863
|
| 4 |
Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 2006; : 2615 doi: 10.1016/B0-44-451005-2/00597-0
|
| 5 |
Adriana Sánchez-García, Mario Simental-Mendía, Luis E. Simental-Mendía. Effect of Proton-Pump Inhibitors on Glucose and Insulin Metabolism on Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Pharmaceutical Design 2020; 26(32): 4007 doi: 10.2174/1381612826666200523170718
|
| 6 |
Javier P. Gisbert, Josep M. Piqué. Indicaciones y consecuencias de la erradicación de Helicobacter pylori en la enfermedad por reflujo gastroesofágico. Medicina Clínica 2005; 124(18): 697 doi: 10.1157/13075094
|
| 7 |
Gerardo M. Castillo, Akiko Nishimoto-Ashfield, Aryamitra A. Banerjee, Jennifer A. Landolfi, Alexander V. Lyubimov, Elijah M. Bolotin. Omeprazole and PGC-Formulated Heparin Binding Epidermal Growth Factor Normalizes Fasting Blood Glucose and Suppresses Insulitis in Multiple Low Dose Streptozotocin Diabetes Model. Pharmaceutical Research 2013; 30(11): 2843 doi: 10.1007/s11095-013-1112-6
|
| 8 |
B. DELANEY, K. McCOLL. Review article: Helicobacter pylori and gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 2005; 22(s1): 32 doi: 10.1111/j.1365-2036.2005.02607.x
|
| 9 |
V. Tolia, K. Boyer. Long-Term Proton Pump Inhibitor Use in Children: A Retrospective Review of Safety. Digestive Diseases and Sciences 2008; 53(2): 385 doi: 10.1007/s10620-007-9880-7
|
| 10 |
Huiqin Gao, Lunan Li, Ke Geng, Changzheng Teng, Yuanyuan Chen, Fei Chu, Yi Zhao. Use of proton pump inhibitors for the risk of gastric cancer. Medicine 2022; 101(49): e32228 doi: 10.1097/MD.0000000000032228
|
| 11 |
Hyun Jin Song, Nakyung Jeon, Patrick Squires. The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2020; 76(10): 1437 doi: 10.1007/s00228-020-02927-8
|
| 12 |
Choo Hean Poh, Tomás Navarro-Rodriguez, Ronnie Fass. Review: Treatment of Gastroesophageal Reflux Disease in the Elderly. The American Journal of Medicine 2010; 123(6): 496 doi: 10.1016/j.amjmed.2009.07.036
|
| 13 |
C. Knippig, P. Malfertheiner. Gastroesophageal Reflux Disease. 2006; : 73 doi: 10.1007/3-211-32317-1_6
|
| 14 |
Michael D Burkitt, Andrea Varro, D Mark Pritchard. Importance of gastrin in the pathogenesis and treatment of gastric tumors. World Journal of Gastroenterology 2009; 15(1): 1-16 doi: 10.3748/wjg.15.1
|
| 15 |
Heloisa B. Assalin, Kelly Cristiane Gabriel De Almeida, Dioze Guadagnini, Andrey Santos, Caio J. Teixeira, Silvana Bordin, Guilherme Z. Rocha, Mario J. A. Saad. Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver. International Journal of Molecular Sciences 2022; 23(22): 13766 doi: 10.3390/ijms232213766
|
| 16 |
A.G. Neto, R.A. Hickman, A. Khan, C. Nossa, Z. Pei. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 1 doi: 10.1016/B978-0-12-804024-9.00001-X
|
| 17 |
Kohzo Takebayashi, Shintaro Sakurai, Tatsuhiko Suzuki, Kenichiro Hori, Tomoko Terasawa, Rika Naruse, Kenji Hara, Mariko Suetsugu, Takafumi Tsuchiya, Hiromi Aoki, Takashi Hamasaki, Hiroshi Shuutou, Toshihiko Inukai. Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes. Endocrine Journal 2014; 61(10): 1031 doi: 10.1507/endocrj.EJ14-0208
|
| 18 |
|
| 19 |
Takahisa Furuta, Naohito Shirai, Mitsushige Sugimoto, Kyoichi Ohashi, Takashi Ishizaki. Pharmacogenomics of proton pump inhibitors. Pharmacogenomics 2004; 5(2): 181 doi: 10.1517/phgs.5.2.181.27483
|
| 20 |
Robert T. Jensen. Consequences of Long‐Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas. Basic & Clinical Pharmacology & Toxicology 2006; 98(1): 4 doi: 10.1111/j.1742-7843.2006.pto_378.x
|
| 21 |
|
| 22 |
Xiao Bai, Si-Qi Ding, Xue-Ping Zhang, Ming-Hao Han, Dong-Qiu Dai. Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses. Cancers 2023; 15(2): 372 doi: 10.3390/cancers15020372
|
| 23 |
Carol Chiung-Hui Peng, Yu-Kang Tu, Gin Yi Lee, Rachel Huai-En Chang, Yuting Huang, Khulood Bukhari, Yao-Chou Tsai, Yunting Fu, Huei-Kai Huang, Kashif M Munir. Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism 2021; 106(11): 3354 doi: 10.1210/clinem/dgab353
|
| 24 |
Takahisa Furuta, Naohito Shirai, Mitsushige Sugimoto, Akiko Nakamura, Akira Hishida, Takashi Ishizaki. Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies. Drug Metabolism and Pharmacokinetics 2005; 20(3): 153 doi: 10.2133/dmpk.20.153
|
| 25 |
A. S. RAGHUNATH, C. O'MORAIN, R. C. MCLOUGHLIN. Review article: the long‐term use of proton‐pump inhibitors. Alimentary Pharmacology & Therapeutics 2005; 22(s1): 55 doi: 10.1111/j.1365-2036.2005.02611.x
|
| 26 |
Kwong Ming Fock, Choo Hean Poh. Gastroesophageal reflux disease. Journal of Gastroenterology 2010; 45(8): 808 doi: 10.1007/s00535-010-0274-9
|
| 27 |
James Reynolds. Practical Gastroenterology and Hepatology Board Review Toolkit. 2016; : 181 doi: 10.1002/9781119127437.ch28
|